Jonathan Wolleben
Stock Analyst at Citizens Capital Markets
(0)
# 2806
Out of 5,298 analysts
202
Total ratings
37.24%
Success rate
4.30%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ALT Altimmune | Reiterates: Market Outperform | 25 25 | 4.46 | 460.54% | 12 | Apr 2, 2025 | |
CLSD Clearside Biomedical | Reiterates: Market Outperform | 5 5 | 0.9 | 455.56% | 10 | Mar 28, 2025 | |
KALV KalVista Pharma | Reiterates: Market Outperform | 19 19 | 11.29 | 68.29% | 3 | Mar 26, 2025 | |
AURA Aura Biosciences | Maintains: Market Outperform | 21 19 | 5.71 | 232.75% | 7 | Mar 26, 2025 | |
SKYE Skye Bioscience | Reiterates: Market Outperform | 15 15 | n/a | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 61 61 | 46.48 | 31.24% | 11 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 22 19 | 6.99 | 171.82% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 10 10 | 7.99 | 25.16% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 55 55 | 14.76 | 272.63% | 11 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 18 18 | 7.33 | 145.57% | 7 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 26 26 | 5.14 | 405.84% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 91 87 | 16.33 | 432.76% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 92 91 | 28.81 | 215.86% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 74 74 | 43.33 | 70.78% | 9 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 427 427 | 327.27 | 30.47% | 11 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 75 75 | 49.78 | 50.66% | 2 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 9 9 | 2.9 | 210.34% | 8 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 55 50 | 34.54 | 44.76% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 90 90 | 76.34 | 17.89% | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Perform | n/a | n/a | n/a | 1 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 1.27 | 529.92% | 6 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 3 3 | 0.29 | 934.48% | 7 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Accumulate | 420 485 | 558.14 | -13.1% | 1 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 3 3 | 0.32 | 837.5% | 6 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Outperform | 48 32 | 2.31 | 1285.28% | 8 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 25 25 | 1.98 | 1162.63% | 11 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Market Outperform | 8 8 | 0.56 | 1328.57% | 11 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 24 | 30.91 | -22.36% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | May 25, 2021 |